Pascal de Groote

13.1k total citations · 4 hit papers
193 papers, 7.0k citations indexed

About

Pascal de Groote is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Pascal de Groote has authored 193 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Cardiology and Cardiovascular Medicine, 59 papers in Pulmonary and Respiratory Medicine and 35 papers in Surgery. Recurrent topics in Pascal de Groote's work include Cardiovascular Function and Risk Factors (53 papers), Heart Failure Treatment and Management (45 papers) and Pulmonary Hypertension Research and Treatments (41 papers). Pascal de Groote is often cited by papers focused on Cardiovascular Function and Risk Factors (53 papers), Heart Failure Treatment and Management (45 papers) and Pulmonary Hypertension Research and Treatments (41 papers). Pascal de Groote collaborates with scholars based in France, United States and United Kingdom. Pascal de Groote's co-authors include Christophe Bauters, Nicolas Lamblin, A Millaire, É. Hachulla, G Ducloux, David Launay, Marc Humbert, Olivier Nugue, Claude Foucher-Hossein and Pierre Clerson and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Pascal de Groote

182 papers receiving 6.8k citations

Hit Papers

Early detection of pulmonary arterial hypertension in sys... 1998 2026 2007 2016 2005 1998 2014 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
    2005 520 citations É. Hachulla, Loı̈c Guillevin et al. profile →
  2. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure
    1998 510 citations Pascal de Groote et al. profile →
  3. Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure
    2014 506 citations Christophe Bauters, Pascal de Groote et al. profile →
  4. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal de Groote France 44 3.9k 2.9k 1.3k 1.1k 1.0k 193 7.0k
Diana Bonderman Austria 41 5.3k 1.3× 4.1k 1.4× 524 0.4× 731 0.7× 1.1k 1.1× 155 8.6k
Ekkehard Grünig Germany 50 6.7k 1.7× 9.4k 3.2× 981 0.8× 1.1k 1.0× 789 0.8× 253 11.5k
Roham T. Zamanian United States 41 2.3k 0.6× 3.9k 1.3× 466 0.4× 633 0.6× 844 0.8× 148 5.3k
J. Simon R. Gibbs United Kingdom 36 3.4k 0.9× 4.6k 1.6× 481 0.4× 563 0.5× 652 0.6× 78 6.0k
Zhi‐Cheng Jing China 39 5.8k 1.5× 8.6k 2.9× 553 0.4× 1.3k 1.2× 1.1k 1.1× 221 10.6k
David G. Kiely United Kingdom 48 3.8k 1.0× 5.6k 1.9× 583 0.5× 446 0.4× 564 0.6× 229 7.0k
Mardi Gomberg‐Maitland United States 45 5.2k 1.3× 7.1k 2.4× 291 0.2× 772 0.7× 951 0.9× 148 8.5k
Seán Gaine Ireland 38 4.0k 1.0× 6.8k 2.3× 603 0.5× 1.0k 0.9× 1.0k 1.0× 143 8.2k
Reda E. Girgis United States 45 3.4k 0.9× 5.9k 2.0× 1.1k 0.9× 498 0.5× 1.8k 1.8× 136 7.7k
Joachim Kienast Germany 40 1.5k 0.4× 865 0.3× 463 0.4× 1.8k 1.7× 787 0.8× 98 7.3k

Countries citing papers authored by Pascal de Groote

Since Specialization
Citations

This map shows the geographic impact of Pascal de Groote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal de Groote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal de Groote more than expected).

Fields of papers citing papers by Pascal de Groote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal de Groote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal de Groote. The network helps show where Pascal de Groote may publish in the future.

Co-authorship network of co-authors of Pascal de Groote

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal de Groote. A scholar is included among the top collaborators of Pascal de Groote based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal de Groote. Pascal de Groote is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longère, Benjamin, et al.. (2025). Photon-counting CT myocardial extracellular volume: A non-invasive biomarker for fibrosis in patients with hypertrophic cardiomyopathy. Diagnostic and Interventional Imaging. 107(1). 17–24.
2.
Boucly, Athénaïs, Antoine Beurnier, Ségolène Turquier, et al.. (2024). Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension. European Respiratory Journal. 64(3). 2400197–2400197. 13 indexed citations
3.
Bouleti, Claire, Benjamin Alos, Damien Legallois, et al.. (2024). Rationale and design of the French Observatory of Acute Heart Failure (OFICA2). Archives of cardiovascular diseases. 117(8-9). 514–520.
4.
Klein, Cédric, Serge Bovéda, Pascal de Groote, et al.. (2023). Remote management in patients with heart failure (from new onset to advanced): A practical guide. Archives of cardiovascular diseases. 117(2). 160–166. 1 indexed citations
5.
Tu, Ly, Christophe Guignabert, Christopher J. Rhodes, et al.. (2023). Cytokines as Prognostic Biomarkers in Pulmonary Arterial Hypertension. A2513–A2513. 1 indexed citations
6.
7.
Jaïs, Xavier, Laurent Savale, Peter Dorfmüller, et al.. (2021). Pulmonary Hypertension in Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology. 41(7). 1549–1562. 5 indexed citations
8.
Hulot, Jean‐Sébastien, Jean‐Noël Trochu, Erwan Donal, et al.. (2021). Vericiguat for the treatment of heart failure: mechanism of action and pharmacological properties compared with other emerging therapeutic options. Expert Opinion on Pharmacotherapy. 22(14). 1847–1855. 29 indexed citations
9.
Boucly, Athénaïs, Jason Weatherald, Laurent Savale, et al.. (2021). External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry. European Respiratory Journal. 59(6). 2102419–2102419. 100 indexed citations
10.
Ader, Flavie, Pascal de Groote, Patricia Réant, et al.. (2020). FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations. Archives of Cardiovascular Diseases Supplements. 12(1). 31–32. 7 indexed citations
11.
Ader, Flavie, Pascal de Groote, Patricia Réant, et al.. (2019). FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype‐phenotype correlations. Clinical Genetics. 96(4). 317–329. 57 indexed citations
12.
Mouquet, Frédéric, et al.. (2012). Unexpected and Rapid Recovery of Left Ventricular Function in Patients with Peripartum Cardiomyopathy: Impact of Cardiac Resynchronization Therapy. European Journal of Heart Failure. 14(5). 526–529. 23 indexed citations
13.
Logeart, Damien, Richard Isnard, Matthieu Resche‐Rigon, et al.. (2012). Current Aspects of the Spectrum of Acute Heart Failure Syndromes in a Real-Life Setting: The OFICA Study. European Journal of Heart Failure. 15(4). 465–476. 117 indexed citations
14.
Lamblin, Nicolas, Anne Bauters, Marie Fertin, et al.. (2011). Circulating Levels of Hepatocyte Growth Factor and Left Ventricular Remodelling After Acute Myocardial Infarction (from the REVE-2 Study). European Journal of Heart Failure. 13(12). 1314–1322. 17 indexed citations
15.
Hachulla, É., David Launay, A. Yaïci, et al.. (2010). Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Lara D. Veeken. 49(5). 940–944. 46 indexed citations
16.
Groote, Pascal de, Richard Isnard, Pierre Clerson, et al.. (2009). Improvement in the Management of Chronic Heart Failure Since the Publication of the Updated Guidelines of the European Society of Cardiology. European Journal of Heart Failure. 11(1). 85–91. 44 indexed citations
17.
Groote, Pascal de, Pierre‐Vladimir Ennezat, & Frédéric Mouquet. (2007). Bisoprolol in the treatment of chronic heart failure. SHILAP Revista de lepidopterología. 6 indexed citations
18.
Groote, Pascal de, Richard Isnard, Pierre Clerson, et al.. (2007). Is the Gap Between Guidelines and Clinical Practice in Heart Failure Treatment Being Filled? Insights from the IMPACT RECO Survey. European Journal of Heart Failure. 9(12). 1205–1211. 97 indexed citations
19.
Launay, David, Pascal de Groote, V. Gaxotte, et al.. (2006). Atteinte cardiaque de la sclérodermie systémique. 2(3). 339–354.
20.
Groote, Pascal de, Nicole Helbecque, Nicolas Lamblin, et al.. (2003). Beta-Adrenergic Receptor Blockade and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients with Chronic Heart Failure. European Journal of Heart Failure. 6(1). 17–21. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Bonderman Breakdown of academic impact, for papers by Ekkehard Grünig Breakdown of academic impact, for papers by Roham T. Zamanian Breakdown of academic impact, for papers by J. Simon R. Gibbs Breakdown of academic impact, for papers by Zhi‐Cheng Jing Breakdown of academic impact, for papers by David G. Kiely Breakdown of academic impact, for papers by Mardi Gomberg‐Maitland Breakdown of academic impact, for papers by Seán Gaine Breakdown of academic impact, for papers by Reda E. Girgis Breakdown of academic impact, for papers by Joachim Kienast
Rankless by CCL
2026